Karampas G, Koulouraki S, Daikos G, Nanou C, Aravantinos L, Eleftheriades M
J Clin Med. 2024; 13(8).
PMID: 38673673
PMC: 11051246.
DOI: 10.3390/jcm13082400.
Alimohmmadian M, Ajdary S, Bahrami F
Iran Biomed J. 2022; 26(2):99-109.
PMID: 35090305
PMC: 8987415.
DOI: 10.52547/ibj.26.2.99.
Chapman L, Morgan A, Adams E, Bern C, Medley G, Hollingsworth T
PLoS Negl Trop Dis. 2018; 12(12):e0006803.
PMID: 30521526
PMC: 6283524.
DOI: 10.1371/journal.pntd.0006803.
Bhattacharya P, Ghosh S, Ejazi S, Rahaman M, Pandey K, Das V
PLoS Negl Trop Dis. 2016; 10(2):e0004422.
PMID: 26829554
PMC: 4735109.
DOI: 10.1371/journal.pntd.0004422.
Romano A, Doria N, Mendez J, Sacks D, Peters N
J Immunol. 2015; 195(8):3816-27.
PMID: 26371247
PMC: 4664083.
DOI: 10.4049/jimmunol.1500752.
Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals.
Kaushal H, Bras-Goncalves R, Negi N, Lemesre J, Papierok G, Salotra P
BMC Infect Dis. 2014; 14:653.
PMID: 25471494
PMC: 4258298.
DOI: 10.1186/s12879-014-0653-6.
Leishmania amazonensis infection impairs dendritic cell migration from the inflammatory site to the draining lymph node.
Hermida M, Doria P, Taguchi A, Mengel J, Dos-Santos W
BMC Infect Dis. 2014; 14:450.
PMID: 25142021
PMC: 4143564.
DOI: 10.1186/1471-2334-14-450.
Immunobiology of visceral leishmaniasis.
Kumar R, Nylen S
Front Immunol. 2012; 3:251.
PMID: 22912637
PMC: 3418610.
DOI: 10.3389/fimmu.2012.00251.
Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.
Gadisa E, Custodio E, Canavate C, Sordo L, Abebe Z, Nieto J
Am J Trop Med Hyg. 2012; 86(5):792-8.
PMID: 22556076
PMC: 3335682.
DOI: 10.4269/ajtmh.2012.11-0196.
Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.
Nation C, Dondji B, Stryker G
Parasitol Res. 2012; 111(3):1407-15.
PMID: 22476599
DOI: 10.1007/s00436-012-2899-5.
Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.
Ravindran R, Anam K, Bairagi B, Saha B, Pramanik N, Guha S
Infect Immun. 2004; 72(2):863-70.
PMID: 14742530
PMC: 321573.
DOI: 10.1128/IAI.72.2.863-870.2004.
Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.
Mukhopadhyay S, Bhattacharyya S, Majhi R, De T, Naskar K, Majumdar S
Clin Diagn Lab Immunol. 2000; 7(2):233-40.
PMID: 10702498
PMC: 95854.
DOI: 10.1128/CDLI.7.2.233-240.2000.
rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.
Zijlstra E, Daifalla N, Kager P, Khalil E, El-Hassan A, Reed S
Clin Diagn Lab Immunol. 1998; 5(5):717-20.
PMID: 9729541
PMC: 95645.
DOI: 10.1128/CDLI.5.5.717-720.1998.
Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.
Rodrigues Jr V, da Silva J, Campos-Neto A
Infect Immun. 1998; 66(3):1233-6.
PMID: 9488418
PMC: 108038.
DOI: 10.1128/IAI.66.3.1233-1236.1998.
Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities.
Chowdhury M, el Harith A, al Massum A, al Karim E, al Rahman A
Parasitol Res. 1993; 79(6):444-50.
PMID: 8415555
DOI: 10.1007/BF00931580.
Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.
Ghosh A, Dasgupta S, Ghose A
Clin Diagn Lab Immunol. 1995; 2(3):291-6.
PMID: 7664174
PMC: 170148.
DOI: 10.1128/cdli.2.3.291-296.1995.
Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.
Carvalho E, Teixeira R, Johnson Jr W
Infect Immun. 1981; 33(2):498-500.
PMID: 7275314
PMC: 350726.
DOI: 10.1128/iai.33.2.498-500.1981.
Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes.
Reiner N
Infect Immun. 1982; 38(3):1223-30.
PMID: 7152667
PMC: 347879.
DOI: 10.1128/iai.38.3.1223-1230.1982.
Protective effect of glucan against visceral leishmaniasis in hamsters.
Cook J, Holbrook T, Dougherty W
Infect Immun. 1982; 37(3):1261-9.
PMID: 7129637
PMC: 347673.
DOI: 10.1128/iai.37.3.1261-1269.1982.
Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
Rezai H, Farrell J, Soulsby E
Clin Exp Immunol. 1980; 40(3):508-14.
PMID: 6968259
PMC: 1538938.
